Search clinical trials for: Bromocriptine Mesylate
Total 1682 results
-
Mylan Pharmaceuticals IncCompleted
-
Mylan Pharmaceuticals IncCompleted
-
VeroScienceCompletedType 2 DiabetesUnited States
-
Jimma UniversityRecruitingDilated CardiomyopathyEthiopia
-
Eastern Virginia Medical SchoolCompletedDiabetic Autonomic NeuropathyUnited States
-
VeroScienceTerminated
-
Eisai LimitedCompleted
-
VeroScienceCompletedType 2 Diabetes Mellitus
-
The University of Texas Health Science Center at...VeroScienceCompletedType 2 DiabetesUnited States
-
University Hospital, BonnUnknownSchizophrenia | HyperprolactinemiaGermany
-
Andrew Moshfeghi, MD, MBACase Western Reserve UniversityWithdrawnDiabetic Macular Edema
-
susanne beckerSNSFCompletedFibromyalgia | Pain, Chronic | Chronic Pain, WidespreadSwitzerland
-
University of BolognaCompletedMyeloid Leukemia, Chronic, Chronic-PhaseItaly
-
Chengdu Zenitar Biomedical Technology Co., LtdCompletedDiffuse Large B Cell Lymphoma，DLBCLChina
-
Novartis PharmaceuticalsCompletedRefractory Desmoplastic Small Round Cell TumorsItaly
-
VA Pittsburgh Healthcare SystemNot yet recruitingSchizophrenia | PreDiabetesUnited States
-
IlDong Pharmaceutical Co LtdCompletedHealthyKorea, Republic of
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationCompletedOverweight and Obesity | Eating BehaviorUnited States
-
National Taiwan University HospitalUnknownHypertension | HyperaldosteronismTaiwan
-
University of Colorado, DenverJuvenile Diabetes Research FoundationCompletedType 1 DiabetesUnited States
-
Eisai Inc.Completed
-
Eisai Co., Ltd.Completed
-
Centre Leon BerardCompletedGastrointestinal Stromal Tumors | Resected Gastrointestinal Stromal Tumors | Non-metastatic | High Risk of Recurrence | KIT Gene MutationFrance
-
Nanjing First Hospital, Nanjing Medical UniversityEnrolling by invitationMain Heading (Descriptor) TermsChina
-
Eisai LimitedCompletedAdvanced Solid TumorFrance
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Eisai Korea Inc.CompletedBreast Cancer | Breast NeoplasmsKorea, Republic of
-
Eisai Inc.Approved for marketingMetastatic Breast CancerCanada, Belgium, France
-
Merz Pharmaceuticals GmbHTerminatedSubjective TinnitusUnited States, United Kingdom, Poland, Austria, Belgium, Brazil, Czech Republic, France, Germany, Mexico, Netherlands, Portugal, South Africa, Spain
-
Pathway Therapeutics, Inc.Completed
-
Merz Pharmaceuticals GmbHTerminatedMultiple Sclerosis | Nystagmus, Congenital | Nystagmus, AcquiredUnited Kingdom
-
Merz Pharmaceuticals GmbHCompleted
-
Boehringer IngelheimCompleted
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Eisai Inc.Completed
-
Eisai Inc.Children's Oncology GroupCompleted
-
Chang Gung Memorial HospitalEisai Co., Ltd.; Kaohsiung Breast Cancer Prevention and Education Society (KBCPES)UnknownAdvanced Breast Cancer | Metastatic Breast CancerTaiwan
-
Eisai Co., Ltd.Completed
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusGermany, Portugal, Spain, United Kingdom, Austria
-
Eisai Inc.Completed
-
Seoul National University HospitalRecruitingAdvanced Breast CancerKorea, Republic of
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingTriple Negative Breast CancerChina
-
National Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusUnited States, Austria, Germany, Brazil, Mexico
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusBelgium, Czech Republic, France, Poland, South Africa, Netherlands
-
University of Texas Southwestern Medical CenterCompletedDiabetes Mellitus, Type 2United States
-
Hunan Cancer HospitalCompletedMetastatic Breast CancerChina
-
Oncologia Medica dell'Ospedale FatebenefratelliMario Negri Institute for Pharmacological ResearchCompletedMetastatic Breast Cancer | Toxicity | Neurotoxicity | Adverse Drug Event | Drug ToxicityItaly
-
InteKrin Therapeutics, Inc.CompletedDiabetes Mellitus, Type IIUnited States